estrone has been researched along with Cancer of Prostate in 79 studies
Hydroxyestrones: Estrone derivatives substituted with one or more hydroxyl groups in any position. They are important metabolites of estrone and other estrogens.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Plasma concentrations of estramustine phosphate and its major metabolites were measured in patients with prostatic carcinoma treated with increasing oral doses, 70-650 mg/day, of estramustine phosphate (Estracyt)." | 7.66 | Plasma concentrations of estramustine phosphate and its major metabolites in patients with prostatic carcinoma treated with different doses of estramustine phosphate (Estracyt). ( Forshell, GP; Fritjofsson, A; Gunnarsson, PO; Norlén, BJ, 1981) |
| "Seeking insight into the possible role of estrogens in prostate cancer (PCa) evolution, we assayed serum E2, estrone (E1), and estrone sulfate (E1S) in 349 PCa and 100 benign prostatic hyperplasia (BPH) patients, and in 208 control subjects in the same age range (50-74 years)." | 3.74 | Estrone sulfate (E1S), a prognosis marker for tumor aggressiveness in prostate cancer (PCa). ( Abbou, CC; Allory, Y; Cussenot, O; de la Taille, A; Fiet, J; Galons, H; Giton, F; Loric, S; Raynaud, JP; Soyeux, P; Vacherot, F, 2008) |
| "Plasma and tumour concentrations of estramustine, estromustine, estradiol and estrone, the major metabolites of estramustine phosphate (estracyt), were determined in patients with prostatic carcinoma treated between one and nine years with repeated oral doses of estracyt (560 to 840 mg." | 3.67 | Uptake of estramustine phosphate (estracyt) metabolites in prostatic cancer. ( Andersson, SB; Björk, P; Fritjofsson, A; Gunnarsson, PO; Norlén, BJ, 1988) |
| "Cortisol, 17-hydroxyprogesterone (17-OH-P), progesterone, testosterone, 5 alpha-dihydrotestosterone (DHT), estrone (E1) and estradiol (E2) were determined by RIA after chromatographic separation of steroids on Sephadex LH-20 columns, in 54 hospitalized patients with benign prostatic hyperplasia (BPH) and in 32 hospitalized patients with prostatic carcinoma (PCA) (T34, N01, M01)." | 3.66 | Plasma steroids in benign prostatic hypertrophy and carcinoma of the prostate. ( Drafta, D; Neacşu, E; Proca, E; Schindler, AE; Stroe, E; Zamfir, V, 1982) |
| "Plasma concentrations of estramustine phosphate and its major metabolites were measured in patients with prostatic carcinoma treated with increasing oral doses, 70-650 mg/day, of estramustine phosphate (Estracyt)." | 3.66 | Plasma concentrations of estramustine phosphate and its major metabolites in patients with prostatic carcinoma treated with different doses of estramustine phosphate (Estracyt). ( Forshell, GP; Fritjofsson, A; Gunnarsson, PO; Norlén, BJ, 1981) |
| "The etiology of prostate cancer remains elusive, although steroid hormones probably play a role." | 2.76 | Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial. ( Ambrosone, CB; Goodman, PJ; Hoque, A; Hsing, A; Kristal, AR; Lippman, SM; Neuhouser, ML; Platz, EA; Reichardt, JK; Santella, RM; Stanczyk, FZ; Tang, L; Tangen, CM; Thompson, IM; Till, C; Wu, Y; Yao, S, 2011) |
| "Patients aged < 60 years with prostate cancer had significantly elevated levels of total testosterone and unconjugated (E1) and total (tE1) oestrone while patients aged > or = 60 years had significantly elevated levels of total and non-SHBG-bound testosterone (NST)." | 2.68 | Testicular and adrenocortical function in men with prostatic cancer and in healthy age-matched controls. ( Carlström, K; Stege, R, 1997) |
| "To investigate prostate cancer (Pca) risk in relation to estrogen metabolism, expressed as urinary 2-hydroxyestrone (2-OHE1), 16alpha-hydroxyestrone (16alpha-OHE1) and 2-OHE1 to 16alpha-OHE1 ratio." | 2.45 | Urinary estrogen metabolites and prostate cancer: a case-control study and meta-analysis. ( Barba, M; Blandino, G; Gallucci, M; Grioni, S; Lauria, R; Malorni, L; Muti, P; Schünemann, HJ; Sperati, F; Stranges, S; Westerlind, KC; Yang, L, 2009) |
| "In castration-resistant prostate cancer patients, levels of androstenedione were significantly associated with testosterone level, while testosterone was the only steroid associated with dihydrotestosterone levels." | 1.72 | Extensive Alteration of Androgen Precursor Levels After Castration in Prostate Cancer Patients and Their Association With Active Androgen Level. ( Caron, P; Guillemette, C; Lacombe, L; Lévesque, É; Morin, F; Neveu, B; Pouliot, F; Rouleau, M; Toren, P; Turcotte, V, 2022) |
| "Risk of aggressive prostate cancer was strongly inversely associated with estradiol:testosterone ratio (OR4th quartile vs." | 1.40 | Sex steroid hormone metabolism in relation to risk of aggressive prostate cancer. ( Black, A; Brinton, LA; Chu, L; Cook, MB; Falk, RT; Grubb, RL; Hoover, RN; Hsing, AW; Meyer, T; Pinsky, PF; Veenstra, TD; Xu, X; Yu, K; Ziegler, RG, 2014) |
| "Finasteride reduces prostate cancer risk by blocking the conversion of testosterone to dihydrotestosterone." | 1.37 | Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study. ( Ambrosone, CB; Figg, WD; Goodman, PJ; Hoque, A; Hsing, AW; Kristal, AR; Lippman, SM; Neuhouser, ML; Parnes, HL; Platz, EA; Price, DK; Reichardt, JK; Santella, RM; Stanczyk, FZ; Tang, L; Tangen, CM; Thompson, IM; Till, C; Yao, S, 2011) |
| "Associations between incident prostate cancer and each sex hormone were evaluated using Cox proportional hazards regression models adjusted for age, race, study site, body mass index, and person-time." | 1.36 | Sex hormones and the risk of incident prostate cancer. ( Bauer, DC; Daniels, NA; Hoffman, AR; Nielson, CM, 2010) |
| "We recruited AA men attending prostate cancer screenings in and around Columbia, South Carolina." | 1.33 | Urinary estrogen metabolites, prostate specific antigen, and body mass index among African-American men in South Carolina. ( Boulware, RJ; Cunningham, JE; Fowke, JH; Hebert, JR; Hurley, TG; Kanwat, CP; Nitcheva, D; Sepkovic, DW; Teas, J, 2005) |
| "To analyze the association of prostate cancer risk with estrogen metabolism, expressed as the ratio of 2-hydroxyestrone (2-OHE1) to 16alpha-hydroxyestrone (16alpha-OHE1), in a case-control study conducted in Buffalo, NY, between 1998 and 2001." | 1.31 | Urinary estrogen metabolites and prostate cancer: a case-control study in the United States. ( Bradlow, L; Carruba, G; De Berry, J; Freudenheim, JL; Grimaldi, T; Hill, H; Muti, P; Schünemann, H; Westerlind, K; Wu, T, 2002) |
| "These data demonstrate that LNCaP prostate cancer cells contain a steryl sulfatase with properties similar to that found in human breast cancer cells, and that the activity of this enzyme can be blocked by known steryl sulfatase inhibitors." | 1.31 | Inhibition of steryl sulfatase activity in LNCaP human prostate cancer cells. ( Kabler, H; Li, PK; Sarap, J; Selcer, KW; Xiao, Z, 2002) |
| " In this study, total testosterone, estrone, estradiol, and sex hormone-binding globulin were not related to prostate cancer, but plasma androstenedione showed a positive dose-response gradient." | 1.28 | A prospective, population-based study of androstenedione, estrogens, and prostatic cancer. ( Barrett-Connor, E; Garland, C; Khaw, KT; McPhillips, JB; Wingard, DL, 1990) |
| "Estracyt is a new drug for treatment of prostatic cancer, which is a molecule combining estradiol and nornitrogen mustard by a carbamate link." | 1.27 | [Pharmacology and metabolism of a new therapeutic drug for prostatic cancer "Estracyt"]. ( Shida, K; Yamanaka, H, 1984) |
| "In these prostatic cancer patients, plasma androgen levels decreased, while estrogen levels increased." | 1.26 | Effect of diet on plasma and urinary hormones in South African black men with prostatic cancer. ( Garbaczewski, L; Hill, P; Walker, AR; Wynder, EL, 1982) |
| "Estrone levels were age invariant in both patients and controls, but the mean level in patients was markedly elevated (81 vs 47 pg/ml in controls; P less than 0." | 1.26 | Abnormal levels of plasma hormones in men with prostate cancer: evidence toward a "two-disease" theory. ( Freed, SZ; Fukushima, DK; Hellman, L; Kream, J; Levin, J; O'Connor, J; Rosenfeld, RS; Strain, GW; Whitmore, WS; Zumoff, B, 1982) |
| " The dosage of the drug was 750 mg." | 1.25 | Prostatic cancer and SCH-13521: II. Histological alterations and the pituitary gonadal axis. ( Daly, JJ; Griffin, PP; Irwin, RJ; Kliman, B; MacLaughlin, RA; Prout, GR, 1975) |
| "In patients with breast and prostate cancer hormone excretion patterns differ in a similar way from patterns in persons without cancer." | 1.24 | HORMONE EXCRETION PATTERNS IN BREAST AND PROSTATE CANCER ARE ABNORMAL. ( HOPKINS, CE; MARMORSTON, J; STERN, E; WEINER, JM, 1964) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 44 (55.70) | 18.7374 |
| 1990's | 9 (11.39) | 18.2507 |
| 2000's | 15 (18.99) | 29.6817 |
| 2010's | 9 (11.39) | 24.3611 |
| 2020's | 2 (2.53) | 2.80 |
| Authors | Studies |
|---|---|
| Emond, JP | 1 |
| Lacombe, L | 2 |
| Caron, P | 2 |
| Turcotte, V | 2 |
| Simonyan, D | 1 |
| Aprikian, A | 1 |
| Saad, F | 1 |
| Carmel, M | 1 |
| Chevalier, S | 1 |
| Guillemette, C | 3 |
| Lévesque, E | 2 |
| Barba, M | 1 |
| Yang, L | 1 |
| Schünemann, HJ | 1 |
| Sperati, F | 1 |
| Grioni, S | 1 |
| Stranges, S | 1 |
| Westerlind, KC | 1 |
| Blandino, G | 1 |
| Gallucci, M | 1 |
| Lauria, R | 1 |
| Malorni, L | 1 |
| Muti, P | 2 |
| Westerlind, K | 1 |
| Wu, T | 1 |
| Grimaldi, T | 1 |
| De Berry, J | 1 |
| Schünemann, H | 1 |
| Freudenheim, JL | 1 |
| Hill, H | 1 |
| Carruba, G | 2 |
| Bradlow, L | 1 |
| Day, JM | 1 |
| Newman, SP | 1 |
| Comninos, A | 1 |
| Solomon, C | 1 |
| Purohit, A | 1 |
| Leese, MP | 1 |
| Potter, BV | 2 |
| Reed, MJ | 1 |
| Mueck, AO | 1 |
| Seeger, H | 1 |
| Lippert, TH | 1 |
| Teas, J | 1 |
| Cunningham, JE | 1 |
| Fowke, JH | 1 |
| Nitcheva, D | 1 |
| Kanwat, CP | 1 |
| Boulware, RJ | 1 |
| Sepkovic, DW | 1 |
| Hurley, TG | 1 |
| Hebert, JR | 1 |
| Markushin, Y | 1 |
| Gaikwad, N | 1 |
| Zhang, H | 1 |
| Kapke, P | 1 |
| Rogan, EG | 1 |
| Cavalieri, EL | 1 |
| Trock, BJ | 1 |
| Pavlovich, C | 1 |
| Jankowiak, R | 1 |
| Hamilton-Reeves, JM | 1 |
| Rebello, SA | 1 |
| Thomas, W | 1 |
| Slaton, JW | 1 |
| Kurzer, MS | 1 |
| Rouleau, M | 1 |
| Neveu, B | 1 |
| Morin, F | 1 |
| Toren, P | 1 |
| Pouliot, F | 1 |
| Black, A | 1 |
| Pinsky, PF | 1 |
| Grubb, RL | 1 |
| Falk, RT | 1 |
| Hsing, AW | 3 |
| Chu, L | 1 |
| Meyer, T | 1 |
| Veenstra, TD | 1 |
| Xu, X | 1 |
| Yu, K | 1 |
| Ziegler, RG | 1 |
| Brinton, LA | 1 |
| Hoover, RN | 1 |
| Cook, MB | 1 |
| Thomas, MP | 1 |
| Schenk, JM | 1 |
| Till, C | 3 |
| Stanczyk, FZ | 3 |
| Gong, Z | 1 |
| Neuhouser, ML | 3 |
| Reichardt, JK | 3 |
| Hoque, AM | 1 |
| Figg, WD | 2 |
| Goodman, PJ | 3 |
| Tangen, CM | 3 |
| Thompson, IM | 3 |
| Daniels, NA | 1 |
| Nielson, CM | 1 |
| Hoffman, AR | 1 |
| Bauer, DC | 1 |
| Thomas, JA | 1 |
| Bañez, L | 1 |
| Freedland, SJ | 1 |
| Tong, da Y | 2 |
| Wen, XQ | 1 |
| Jin, Y | 2 |
| Liu, ZW | 2 |
| Sun, HY | 2 |
| Zhou, FJ | 2 |
| Wu, XY | 2 |
| Yao, S | 2 |
| Kristal, AR | 2 |
| Platz, EA | 2 |
| Tang, L | 2 |
| Santella, RM | 2 |
| Price, DK | 1 |
| Parnes, HL | 1 |
| Lippman, SM | 2 |
| Ambrosone, CB | 2 |
| Hoque, A | 2 |
| Wu, Y | 1 |
| Hsing, A | 1 |
| Selcer, KW | 1 |
| Kabler, H | 1 |
| Sarap, J | 1 |
| Xiao, Z | 1 |
| Li, PK | 1 |
| MASCHIO, C | 1 |
| DUNNING, WF | 1 |
| MAHONEY, SA | 1 |
| PERSKY, L | 1 |
| ZIMMERMANN, W | 1 |
| BUESCHER, HK | 1 |
| TAUPITZ, A | 1 |
| THEWALT, K | 1 |
| BRADSHAW, LR | 1 |
| BAGNESS, JE | 1 |
| PYRAH, LN | 1 |
| RAPER, FP | 1 |
| STERN, E | 3 |
| HOPKINS, CE | 3 |
| WEINER, JM | 2 |
| MARMORSTON, J | 3 |
| LOMBARDO, LJ | 1 |
| MYERS, SM | 1 |
| GIERSON, H | 1 |
| ACEVEDO, HF | 1 |
| GOLDZIEHER, JW | 1 |
| DEVOS, R | 1 |
| Nakamura, Y | 1 |
| Suzuki, T | 1 |
| Fukuda, T | 1 |
| Ito, A | 1 |
| Endo, M | 1 |
| Moriya, T | 1 |
| Arai, Y | 1 |
| Sasano, H | 1 |
| Giton, F | 1 |
| de la Taille, A | 1 |
| Allory, Y | 1 |
| Galons, H | 1 |
| Vacherot, F | 1 |
| Soyeux, P | 1 |
| Abbou, CC | 1 |
| Loric, S | 1 |
| Cussenot, O | 1 |
| Raynaud, JP | 1 |
| Fiet, J | 1 |
| Belis, JA | 2 |
| Coffey, DS | 1 |
| Isaacs, JT | 1 |
| Hill, P | 1 |
| Wynder, EL | 2 |
| Garbaczewski, L | 1 |
| Walker, AR | 1 |
| Drafta, D | 1 |
| Proca, E | 1 |
| Zamfir, V | 1 |
| Schindler, AE | 1 |
| Neacşu, E | 1 |
| Stroe, E | 1 |
| Sandberg, AA | 2 |
| Forsgren, B | 1 |
| Björk, P | 3 |
| Gunnarsson, PO | 5 |
| Forshell, GP | 2 |
| Yamanaka, H | 1 |
| Shida, K | 1 |
| Rose, DP | 1 |
| Laakso, K | 1 |
| Sotarauta, M | 1 |
| Kirdani, RY | 1 |
| Karr, JP | 1 |
| Murphy, GP | 1 |
| Zumoff, B | 2 |
| Levin, J | 2 |
| Strain, GW | 1 |
| Rosenfeld, RS | 1 |
| O'Connor, J | 1 |
| Freed, SZ | 2 |
| Kream, J | 1 |
| Whitmore, WS | 1 |
| Fukushima, DK | 2 |
| Hellman, L | 3 |
| Meikle, AW | 1 |
| Stanish, WM | 1 |
| Ahluwalia, B | 1 |
| Jackson, MA | 1 |
| Jones, GW | 1 |
| Williams, AO | 1 |
| Rao, MS | 1 |
| Rajguru, S | 1 |
| Tarry, WF | 1 |
| Fritjofsson, A | 2 |
| Norlén, BJ | 2 |
| Whitmore, WF | 1 |
| Fishman, J | 2 |
| Leinonen, P | 1 |
| Hum, DW | 1 |
| Bélanger, A | 1 |
| Carlström, K | 3 |
| Stege, R | 3 |
| Mäkelä, S | 1 |
| Poutanen, M | 1 |
| Kostian, ML | 1 |
| Lehtimäki, N | 1 |
| Strauss, L | 1 |
| Santti, R | 1 |
| Vihko, R | 1 |
| Walz, PH | 1 |
| Edman, K | 1 |
| Hartley-Asp, B | 1 |
| Wang, LG | 1 |
| Liu, XM | 1 |
| Kreis, W | 1 |
| Budman, DR | 1 |
| Grande, M | 2 |
| Pousette, A | 2 |
| Faxén, M | 2 |
| Penning, TM | 1 |
| Burczynski, ME | 1 |
| Jez, JM | 1 |
| Lin, HK | 1 |
| Ma, H | 1 |
| Moore, M | 1 |
| Ratnam, K | 1 |
| Palackal, N | 1 |
| Le Lain, R | 1 |
| Nicholls, PJ | 1 |
| Smith, HJ | 1 |
| Maharlouie, FH | 1 |
| Webber, MM | 1 |
| Quader, ST | 1 |
| Amoroso, M | 1 |
| Cocciadiferro, L | 1 |
| Saladino, F | 1 |
| Trosko, JE | 1 |
| Castagnetta, LA | 1 |
| Nishikawa, G | 1 |
| Wahren, B | 1 |
| Schweikert, HU | 1 |
| Steg, A | 1 |
| Benoit, G | 1 |
| Noble, RL | 3 |
| Payne, AH | 1 |
| Kelch, RP | 1 |
| Musich, SS | 1 |
| Halpern, ME | 1 |
| Prout, GR | 1 |
| Irwin, RJ | 1 |
| Kliman, B | 1 |
| Daly, JJ | 1 |
| MacLaughlin, RA | 1 |
| Griffin, PP | 1 |
| de Launoit, Y | 1 |
| Veilleux, R | 1 |
| Dufour, M | 1 |
| Simard, J | 1 |
| Labrie, F | 1 |
| Pusateri, DJ | 1 |
| Roth, WT | 1 |
| Ross, JK | 1 |
| Shultz, TD | 1 |
| Barrett-Connor, E | 1 |
| Garland, C | 1 |
| McPhillips, JB | 1 |
| Khaw, KT | 1 |
| Wingard, DL | 1 |
| Davidsson, T | 1 |
| Andersson, SB | 2 |
| Backman, C | 1 |
| Johansson, SA | 1 |
| Rannikko, S | 1 |
| Adlercreutz, H | 1 |
| Haapiainen, R | 1 |
| Huot, RI | 1 |
| Shain, SA | 1 |
| Carroll, KK | 1 |
| Brehmer, B | 1 |
| Marquardt, H | 1 |
| Madsen, PO | 1 |
| Kaul, P | 1 |
| Prasad, GC | 1 |
| Gupta, RC | 1 |
| Udupa, KN | 1 |
| Alfthan, OS | 1 |
| Scott, WW | 1 |
| Schirmer, HK | 1 |
6 reviews available for estrone and Cancer of Prostate
| Article | Year |
|---|---|
Urinary estrogen metabolites and prostate cancer: a case-control study and meta-analysis.
Topics: Aged; Case-Control Studies; Chromatography, Liquid; Estrogens; Humans; Hydroxyestrones; Male; Mass S | 2009 |
[Estrogen-dependent neoplasia - what is the significance of estradiol metabolites].
Topics: 2-Methoxyestradiol; Anticarcinogenic Agents; Breast Neoplasms; Estradiol; Estrogens, Catechol; Femal | 2003 |
Control of prostate growth.
Topics: Adrenal Glands; Adult; Aged; Dihydrotestosterone; Estradiol; Estrone; Follicle Stimulating Hormone; | 1981 |
Metabolic parameters of Estracyt pertinent to its effects in prostatic cancer.
Topics: Adenocarcinoma; Animals; Bile; Biotransformation; Estradiol; Estramustine; Estrone; Half-Life; Human | 1984 |
Specific binding of estramustine to prostatic proteins.
Topics: Animals; Carrier Proteins; Cytosol; Epithelium; Estradiol; Estramustine; Estrone; Humans; Male; Nitr | 1984 |
Clinical pharmacokinetics of estramustine phosphate.
Topics: Absorption; Dose-Response Relationship, Drug; Estradiol; Estramustine; Estrone; Feces; Half-Life; Hu | 1984 |
4 trials available for estrone and Cancer of Prostate
| Article | Year |
|---|---|
Soy protein isolate increases urinary estrogens and the ratio of 2:16alpha-hydroxyestrone in men at high risk of prostate cancer.
Topics: Aged; Estrogens; Humans; Hydroxyestrones; Male; Middle Aged; Phytoestrogens; Prostatic Neoplasms; So | 2007 |
Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial.
Topics: Aromatase; Case-Control Studies; Cholesterol Side-Chain Cleavage Enzyme; DNA; Estradiol; Estrogens; | 2011 |
Testicular and adrenocortical function in men with prostatic cancer and in healthy age-matched controls.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Cortex Hormones; Aged; Aged, 80 and over; Estrone; Gonadal Ste | 1997 |
Impairment of estramustine phosphate absorption by concurrent intake of milk and food.
Topics: Aged; Animals; Biological Availability; Chromatography, Gas; Estramustine; Estrone; Food; Humans; Ma | 1990 |
69 other studies available for estrone and Cancer of Prostate
| Article | Year |
|---|---|
Urinary oestrogen steroidome as an indicator of the risk of localised prostate cancer progression.
Topics: Aged; Disease Progression; Estradiol; Humans; Hydroxyestrones; Male; Mass Spectrometry; Middle Aged; | 2021 |
Urinary estrogen metabolites and prostate cancer: a case-control study in the United States.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Case-Control Studies; Humans; Hydroxyestrones; Logistic Mod | 2002 |
The effects of 2-substituted oestrogen sulphamates on the growth of prostate and ovarian cancer cells.
Topics: 2-Methoxyestradiol; Apoptosis; Cell Division; Cell Separation; Estradiol; Estrone; Female; Flow Cyto | 2003 |
Urinary estrogen metabolites, prostate specific antigen, and body mass index among African-American men in South Carolina.
Topics: Adult; Aged; Black or African American; Body Mass Index; Estrogens; Humans; Hydroxyestrones; Male; M | 2005 |
Potential biomarker for early risk assessment of prostate cancer.
Topics: Antibodies, Monoclonal; Biomarkers, Tumor; DNA Adducts; Early Diagnosis; Electrophoresis, Capillary; | 2006 |
Extensive Alteration of Androgen Precursor Levels After Castration in Prostate Cancer Patients and Their Association With Active Androgen Level.
Topics: Androgen Antagonists; Androgens; Androstenedione; Androsterone; Dehydroepiandrosterone; Dihydrotesto | 2022 |
Sex steroid hormone metabolism in relation to risk of aggressive prostate cancer.
Topics: Aged; Case-Control Studies; Estradiol; Estrogens; Estrone; Gonadal Steroid Hormones; Humans; Male; M | 2014 |
Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health.
Topics: Animals; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Drug Discovery; Endometriosi | 2015 |
Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention Trial.
Topics: Aged; Androgens; Androstane-3,17-diol; Arm; Biopsy; Case-Control Studies; Estradiol; Estrone; Humans | 2016 |
Sex hormones and the risk of incident prostate cancer.
Topics: Aged; Case-Control Studies; Cohort Studies; Estradiol; Estrone; Gas Chromatography-Mass Spectrometry | 2010 |
Editorial comment. Sex hormones and the risk of incident prostate cancer.
Topics: Aged; Androgens; Estrogens; Estrone; Gonadal Steroid Hormones; Humans; Male; Prostatic Neoplasms; Ri | 2010 |
Changes of androgen receptor and insulin-like growth factor-1 in LNCaP prostate cancer cells treated with sex hormones and flutamide.
Topics: Androgen Antagonists; Androgens; Blotting, Western; Cell Line, Tumor; Dihydrotestosterone; Estrogens | 2010 |
Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study.
Topics: 5-alpha Reductase Inhibitors; Aged; Aged, 80 and over; Case-Control Studies; Estradiol; Estrone; Fem | 2011 |
Expression changes and regulation of AR and IGF-1 in PC3 prostate cancer cells treated with sexual hormones and flutamide.
Topics: Androgen Antagonists; Androgens; Blotting, Western; Dihydrotestosterone; Estrogens; Estrone; Flutami | 2012 |
Inhibition of steryl sulfatase activity in LNCaP human prostate cancer cells.
Topics: Arylsulfatases; Breast Neoplasms; Danazol; Dehydroepiandrosterone Sulfate; Enzyme Inhibitors; Estron | 2002 |
[Hemorrhagic chromophobe adenoma of pituitary gland in a patient with cancer of prostate treated with folliculin].
Topics: Adenoma, Chromophobe; Estrogens; Estrone; Humans; Male; Neoplasms; Pituitary Gland; Pituitary Neopla | 1954 |
PROSTATE CANCER IN THE RAT.
Topics: Androgens; Estradiol Congeners; Estrogens; Estrone; Humans; Male; Mechlorethamine; Neoplasms; Neopla | 1963 |
HORMONAL INFLUENCES ON THE NUCLEIC ACID METABOLISM OF THE HUMAN PROSTATE IN VITRO: A PILOT STUDY.
Topics: Carbon Isotopes; DNA; Estrone; Formates; Humans; In Vitro Techniques; Male; Metabolism; Pharmacology | 1963 |
[STEROID HORMONE EXCRETION OF PATIENTS WITH DISEASES OF THE PROSTATE UNDER TREATMENT WITH NATURAL AND SYNTHETIC ESTROGENS].
Topics: 17-Ketosteroids; Adenoma; Adrenal Cortex Hormones; Carcinoma; Estradiol; Estradiol Congeners; Estrio | 1964 |
A STUDY OF STEROID EXCRETION IN PATIENTS WITH PROSTATIC CANCER.
Topics: 17-Ketosteroids; Adrenal Cortex Hormones; Androsterone; Biopsy; Cortisone; Dehydroepiandrosterone; D | 1964 |
HORMONE EXCRETION PATTERNS IN BREAST AND PROSTATE CANCER ARE ABNORMAL.
Topics: 17-Ketosteroids; Adrenal Cortex Hormones; Aged; Androsterone; Breast Neoplasms; Creatine; Creatinine | 1964 |
URINARY EXCRETION OF ESTRONE, ESTRADIOL AND ESTRIOL BY PATIENTS WITH PROSTATIC CANCER AND BENIGN PROSTATIC HYPERTROPHY.
Topics: Androsterone; Estradiol; Estriol; Estrone; Humans; Male; Mice; Prostatic Hyperplasia; Prostatic Neop | 1965 |
THE METABOLISM OF (14C)ESTRONE BY HYPERTROPHIC AND CARCINOMATOUS HUMAN PROSTATE TISSUE.
Topics: Chromatography; Diethylstilbestrol; Estradiol; Estrogens; Estrone; Humans; Hydroxysteroid Dehydrogen | 1965 |
[Cancer of the prostate treated by folliculin; results after nine years].
Topics: Contraceptive Agents, Female; Estradiol Congeners; Estrogens; Estrone; Female; Humans; Male; Neoplas | 1950 |
Steroid sulfatase and estrogen sulfotransferase in human prostate cancer.
Topics: Cell Line, Tumor; Estradiol; Estrone; Humans; Immunohistochemistry; Male; Prostatic Neoplasms; Stery | 2006 |
Estrone sulfate (E1S), a prognosis marker for tumor aggressiveness in prostate cancer (PCa).
Topics: Adult; Aged; Androgens; Biomarkers, Tumor; Blood Chemical Analysis; Case-Control Studies; Estradiol; | 2008 |
Methodologic basis for the radioimmunoassay of endogenous steroids in human prostatic tissue.
Topics: Adenocarcinoma; Adult; Aged; Dihydrotestosterone; Estradiol; Estrone; Humans; Male; Middle Aged; Pro | 1980 |
Effect of diet on plasma and urinary hormones in South African black men with prostatic cancer.
Topics: Aged; Androgens; Androsterone; Black People; Dehydroepiandrosterone; Diet; Estriol; Estrogens; Estro | 1982 |
Plasma steroids in benign prostatic hypertrophy and carcinoma of the prostate.
Topics: 17-alpha-Hydroxyprogesterone; Age Factors; Aged; Dihydrotestosterone; Estradiol; Estrone; Humans; Hy | 1982 |
[Pharmacology and metabolism of a new therapeutic drug for prostatic cancer "Estracyt"].
Topics: Animals; Antineoplastic Agents; Estramustine; Estrone; Follicle Stimulating Hormone; Humans; Luteini | 1984 |
Hormone levels in prostatic fluid from healthy finns and prostate cancer patients.
Topics: Body Fluids; Estradiol; Estrone; Hormones; Humans; Male; Prolactin; Prostate; Prostatic Neoplasms; T | 1984 |
Prostate cancer; plasma concentrations of estramustine phosphate and its metabolites.
Topics: Estradiol; Estramustine; Estrone; Humans; Male; Nitrogen Mustard Compounds; Prostatic Neoplasms | 1980 |
Abnormal levels of plasma hormones in men with prostate cancer: evidence toward a "two-disease" theory.
Topics: Age Factors; Aged; Dihydrotestosterone; Estrone; Hormones; Humans; Hydrocortisone; Male; Middle Aged | 1982 |
Familial prostatic cancer risk and low testosterone.
Topics: Dihydrotestosterone; Estradiol; Estrone; Humans; Male; Middle Aged; Prostatic Neoplasms; Risk; Sex H | 1982 |
Blood hormone profiles in prostate cancer patients in high-risk and low-risk populations.
Topics: Acid Phosphatase; Age Factors; Aged; Black or African American; Black People; Estrone; Hormones; Hum | 1981 |
Radioimmunoassay of tissue steroids in adenocarcinoma of the prostate.
Topics: Adenocarcinoma; Biopsy, Needle; Dihydrotestosterone; Estradiol; Estrone; Hormones; Humans; Male; Pro | 1981 |
Plasma concentrations of estramustine phosphate and its major metabolites in patients with prostatic carcinoma treated with different doses of estramustine phosphate (Estracyt).
Topics: Administration, Oral; Aged; Carcinoma; Estradiol; Estramustine; Estrone; Humans; Male; Middle Aged; | 1981 |
Metabolism of 3H-estradiol in men with prostate cancer.
Topics: Aged; Estradiol; Estriol; Estrone; Humans; Male; Middle Aged; Prostatic Neoplasms | 1980 |
Estrone and estradiol concentrations in the testis and spermatic and peripheral venous blood of elderly men: the influence of estrogen treatment.
Topics: Aged; Estradiol; Estrone; Humans; Male; Middle Aged; Organophosphorus Compounds; Prostatic Neoplasms | 1980 |
Specificity of glucuronosyltransferase activity in the human cancer cell line LNCaP, evidence for the presence of at least two glucuronosyltransferase enzymes.
Topics: Adenocarcinoma; Androstane-3,17-diol; Androsterone; Binding, Competitive; Dihydrotestosterone; Estra | 1995 |
Inhibition of 17beta-hydroxysteroid oxidoreductase by flavonoids in breast and prostate cancer cells.
Topics: 17-Hydroxysteroid Dehydrogenases; Breast Neoplasms; Enzyme Inhibitors; Estradiol; Estrone; Female; F | 1998 |
Differential uptake of estramustine phosphate metabolites and its correlation with the levels of estramustine binding protein in prostate tumor tissue.
Topics: Aged; Antineoplastic Agents, Hormonal; Carrier Proteins; Estradiol; Estramustine; Estrone; Humans; M | 1998 |
Androgen antagonistic effect of estramustine phosphate (EMP) metabolites on wild-type and mutated androgen receptor.
Topics: Androgen Antagonists; Antineoplastic Agents, Alkylating; Binding, Competitive; Estramustine; Estroge | 1998 |
Estrogens increase the endothelial nitric oxide synthase (ecNOS) mRNA level in LNCaP human prostate carcinoma cells.
Topics: Endothelium; Estradiol; Estrone; Humans; Male; Nitric Oxide Synthase; Prostatic Neoplasms; RNA, Mess | 2000 |
Structure-function aspects and inhibitor design of type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3).
Topics: 17-Hydroxysteroid Dehydrogenases; 20-alpha-Dihydroprogesterone; 3-alpha-Hydroxysteroid Dehydrogenase | 2001 |
Inhibitors of human and rat testes microsomal 17beta-hydroxysteroid dehydrogenase (17beta-HSD) as potential agents for prostatic cancer.
Topics: 17-Hydroxysteroid Dehydrogenases; Androstenedione; Animals; Benzoquinones; Drug Evaluation, Preclini | 2001 |
Regulation of cell-to-cell communication in non-tumorigenic and malignant human prostate epithelial cells.
Topics: Cell Communication; Cell Transformation, Neoplastic; Colforsin; Connexins; Epithelial Cells; Estrone | 2002 |
Estrogens affect endothelin-1 mRNA expression in LNCaP human prostate carcinoma cells.
Topics: Biomarkers, Tumor; Endothelin-1; Estradiol; Estrogen Receptor beta; Estrone; Gene Expression; Humans | 2002 |
[Tissue culture of the human prostate--effects of sex hormones on subcultures of cells from benign prostatic hyperplasia and carcinoma of the prostate (author's transl)].
Topics: Adenocarcinoma; Cell Count; Cell Division; Culture Techniques; Diethylstilbestrol; Dihydrotestostero | 1978 |
Tumour markers in urology: aids in cancer diagnosis and management.
Topics: Acid Phosphatase; Alkaline Phosphatase; alpha 1-Antitrypsin; alpha-Fetoproteins; Antibodies, Neoplas | 1979 |
Conversion of androstenedione to estrone in human fibroblasts cultured from prostate, genital and nongenital skin.
Topics: Adolescent; Adult; Aged; Androstenedione; Cells, Cultured; Estrone; Fibroblasts; Humans; Kinetics; M | 1979 |
Percutaneous 17 beta-estradiol in treatment of cancer of prostate.
Topics: Adenocarcinoma; Dihydrotestosterone; Estradiol; Estrone; Follicle Stimulating Hormone; Humans; Lipop | 1979 |
The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration.
Topics: Adenocarcinoma; Animals; Drug Synergism; Estrone; Male; Neoplasms, Experimental; Prostatic Neoplasms | 1977 |
Sex steroids as a cause of adenocarcinoma of the dorsal prostate in Nb rats, and their influence on the growth of transplants.
Topics: Adenocarcinoma; Androgens; Animals; Estrogens; Estrone; Male; Neoplasm Transplantation; Neoplasms, E | 1977 |
Intratesticular site of aromatization in the human.
Topics: Adult; Aged; Androstenedione; Estradiol; Estrone; Humans; Infant; Male; Middle Aged; Prostatic Neopl | 1976 |
Prostatic cancer and SCH-13521: II. Histological alterations and the pituitary gonadal axis.
Topics: Aged; Anilides; Biopsy, Needle; Cerebrovascular Disorders; Estradiol; Estrone; Flutamide; Follicle S | 1975 |
Characteristics of the biphasic action of androgens and of the potent antiproliferative effects of the new pure antiestrogen EM-139 on cell cycle kinetic parameters in LNCaP human prostatic cancer cells.
Topics: Androgens; Androstane-3,17-diol; Binding, Competitive; Cell Cycle; Dihydrotestosterone; Dose-Respons | 1991 |
Dietary and hormonal evaluation of men at different risks for prostate cancer: plasma and fecal hormone-nutrient interrelationships.
Topics: Adult; Aged; Christianity; Diet; Dietary Fiber; Energy Metabolism; Estradiol; Estrone; Fatty Acids; | 1990 |
A prospective, population-based study of androstenedione, estrogens, and prostatic cancer.
Topics: Adult; Aged; Androstenedione; California; Cohort Studies; Estradiol; Estrone; Humans; Male; Middle A | 1990 |
Urinary oestrogen excretion in benign prostatic hyperplasia and prostatic cancer.
Topics: Aged; Aged, 80 and over; Estradiol; Estriol; Estrogens; Estrone; Humans; Male; Middle Aged; Prostati | 1989 |
Differential metabolism of dehydroepiandrosterone sulfate and estrogen conjugates by normal or malignant AXC/SSh rat prostate cells and effects of these steroid conjugates on cancer cell proliferation in vitro.
Topics: Animals; Cell Division; Cell Line; Clone Cells; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfa | 1988 |
Uptake of estramustine phosphate (estracyt) metabolites in prostatic cancer.
Topics: Aged; Carcinoma; Carrier Proteins; Estradiol; Estramustine; Estrone; Humans; Male; Middle Aged; Nitr | 1988 |
Dietary fat in relation to hormonal induction of mammary and prostatic carcinoma in Nb rats.
Topics: Animals; Dietary Fats; Estrone; Female; Kinetics; Male; Mammary Neoplasms, Experimental; Prostatic N | 1987 |
Growth and hormonal response of cells derived from carcinoma and hyperplasia of the prostate in monolayer cell culture. A possible in vitro model for clinical chemotherapy.
Topics: Adenocarcinoma; Androsterone; Carcinoma; Cell Division; Cells, Cultured; Diethylstilbestrol; Estrone | 1972 |
Urinary hormone metabolites in cancer and benign hyperplasia of the prostate: a multivariate statistical analysis.
Topics: 17-Ketosteroids; Adenocarcinoma; Adrenal Cortex Hormones; Estriol; Estrone; Hormones; Humans; Male; | 1966 |
A comparative study of urinary oestrogens in the cancer of breast and prostate.
Topics: Adult; Aged; Breast Neoplasms; Estradiol; Estriol; Estrogens; Estrone; Female; Humans; Male; Middle | 1974 |
Oestradiol production rates in man before and after orchiectomy for cancer.
Topics: Aged; Breast Neoplasms; Castration; Estradiol; Estriol; Estrone; Humans; Male; Middle Aged; Prostati | 1970 |
The inhibiting effect of irradiation on gynecomastia induced by estrogen hormone stimulation: an experimental study.
Topics: Animals; Castration; Estrogens; Estrone; Gynecomastia; Male; Mammary Glands, Animal; Prostatic Neopl | 1969 |
A new oral progestational steroid effective in treating prostatic cancer.
Topics: Acid Phosphatase; Aged; Animals; Biological Assay; Castration; Dogs; Estradiol; Estrone; Humans; Liv | 1966 |